National Bank Of Canada Invitae Corp Transaction History

National Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$0.42 - $0.72 $833 - $1,429	1,985 Added 502.53%	2,380 $1,000
Q1 2023 Apr 12, 2023	SELL	$1.2 - $2.73 $840 - $1,911	-700 Reduced 63.93%	395 $0
Q3 2022 Oct 13, 2022	SELL	$1.9 - $8.63 $10,070 - $45,739	-5,300 Reduced 82.88%	1,095 $1,000
Q2 2022 Jul 28, 2022	BUY	$2.13 - $9.01 $12,667 - $53,582	5,947 Added 1327.46%	6,395 $15,000
Q1 2022 May 05, 2022	SELL	$6.28 - $15.59 $194 - $483	-31 Reduced 6.47%	448 $4,000

Q4 2021 Jan 24, 2022	BUY	$14.7 - $28.67 $7,041 - $13,732	479 New	479 $7,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.